Inclusion complex of a Bcl-2 inhibitor with cyclodextrin: characterization, cellular accumulation, and in vivo antitumor activity. Molecular Pharmacology.
Release Time:2019-03-12 Hits:
Indexed by: Journal Article
Date of Publication: 2010-01-01
Journal: Molecular Pharmaceutics
Volume: 7
Issue: 55
Page Number: 1347-1354
Prev One:3-Thiomorpholin-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile (S1) Based Molecules as Potent, Dual Inhibitors of B-Cell Lymphoma 2 (Bcl-2) and Myeloid Cell Leukemia Sequence 1 (Mcl-1):
Next One:A novel BH3 mimetic S1 potently induces Bax/Bak-dependent apoptosis by targeting both Bcl-2 and Mcl-1.